Product Program year 2024 Source: CMS Open Payments

Allure

Device Cardiac Rhythm Management

PDI 05414734507905

Open in the dashboard

General payments

$299,844

740 payments

Research payments

$0

0 payments

Through program year 2024, $299,844 in general payments and $0 in research payments were reported against Allure (Cardiac Rhythm Management).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

3 rows
Year Kind Amount Payments
2024 General $10,235 60
2023 General $47,594 173
2022 General $242,015 507

Breakdown

Who paid General payments · program years 2022–2024
  1. Abbott Laboratories $299,844 740 payments
Top recipients General payments · program year 2024
  1. Joshua Stern Internal Medicine · New Hyde Park, NY $3,613 35% · 7 payments
  2. Michael Pittaro Clinical Cardiac Electrophysiology · Stamford, CT $3,400 33% · 3 payments
  3. Murlidhar Amin Cardiovascular Disease · Port Arthur, TX $700 7% · 1 payment
  4. Nathan Reed Clinical Cardiac Electrophysiology · Newburgh, IN $700 7% · 2 payments
  5. Thomas Hong Clinical Cardiac Electrophysiology · Houston, TX $571 6% · 3 payments

The top 5 of 43 recipients; each share is of general payments naming this product in 2024.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2024
  1. Clinical Cardiac Electrophysiology Internal Medicine $5,465 53% · 21 practitioners
  2. Internal Medicine $3,613 35% · 1 practitioner
  3. Cardiovascular Disease Internal Medicine $908 9% · 10 practitioners
  4. Physician Assistant $86 <1% · 3 practitioners
  5. Thoracic Surgery (Cardiothoracic Vascular Surgery) $41 <1% · 1 practitioner

The top 5 of 11 specialties; each share is of general payments naming this product to practitioners with a specialty in 2024. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2024
  1. New York $3,631 35% · 3 recipients
  2. Connecticut $3,474 34% · 4 recipients
  3. Texas $1,865 18% · 10 recipients
  4. Indiana $828 8% · 6 recipients
  5. Iowa $83 <1% · 2 recipients

The top 5 of 16 states; each share is of general payments naming this product in 2024 where a state was reported.

The top 25 states, free in the app

740 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2024

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record